Allergy to Gibberellin-regulated proteins in an adolescent: A case of orange-induced anaphylaxis mediated by cofactors
Main Article Content
Keywords
Anaphylaxis, Gibberellin-Regulated Proteins, Allergic Pediatric Patients, Cofactor
Abstract
This report is a case of anaphylaxis in an adolescent due to allergy to gibberellin-regulated proteins mediated by cofactors, in probable relation to a pollen/food allergy syndrome. It should also emphasizes the importance of obtaining a faithful clinical history, especially when it comes to adolescent patients as they tend to initiate toxic habits.
References
1. Tanno LK, Demoly, P. Anaphylaxis in children. Pediatr Allergy Immunol. 2020; 31(Suppl. 26): 8–10. 10.1111/pai.13336
2. Aun MV, Kalil J, Giavina-Bianchi P. Adults and children with anaphylaxis in the emergency room: Why it is not recognized? Curr Opin Allergy Clin Immunol. 2018; 18:377–81. 10.1097/ACI.0000000000000469
3. Iizuka T, Barre A, Rougé P, Charpin D, Scala E, Baudin B, et al. Gibberellin-regulated proteins: Emergent allergens. Frontiers in allergy. 2022; 3: 877553. 10.3389/falgy.2022.877553
4. Inomata N. Gibberellin-regulated protein allergy: Clinical features and cross-reactivity. Allergol Int. 2020;69(1):11–18. 10.1016/j.alit.2019.10.007
5. Poncet P, Sénéchal H, Charpin D. Update on pollen-food allergy syndrome. Expert Rev Clin Immunol. 2020;16(6): 561–578. 10.1080/1744666X.2020.1774366
6. Inomata N, Miyakawa M, Ikeda N, Oda K, Aihara M. Identification of gibberellin-regulated protein as a new allergen in orange allergy. Clin Exp Allergy. 2018;48(11):1509–1520. 10.1111/cea.13247
7. Carlson G, Coop C. Pollen food allergy syndrome (PFAS): A review of current available literature. Ann Allergy Asthma Immunol. 2019;123(4):359–365. 10.1016/j.anai.2019.07.022
8. Skypala IJ, Jeimy S, Brucker H, et al. Cannabis-related allergies: An international overview and consensus recommendations. Allergy. 2022;77(7):2038–2052. 10.1111/all.15237
9. Asaumi T, Ebisawa M. How to manage food dependent exercise induced anaphylaxis (FDEIA). Curr Opin Allergy Clin Immunol. 2018;18(3):243–247. 10.1097/ACI.0000000000000442
2. Aun MV, Kalil J, Giavina-Bianchi P. Adults and children with anaphylaxis in the emergency room: Why it is not recognized? Curr Opin Allergy Clin Immunol. 2018; 18:377–81. 10.1097/ACI.0000000000000469
3. Iizuka T, Barre A, Rougé P, Charpin D, Scala E, Baudin B, et al. Gibberellin-regulated proteins: Emergent allergens. Frontiers in allergy. 2022; 3: 877553. 10.3389/falgy.2022.877553
4. Inomata N. Gibberellin-regulated protein allergy: Clinical features and cross-reactivity. Allergol Int. 2020;69(1):11–18. 10.1016/j.alit.2019.10.007
5. Poncet P, Sénéchal H, Charpin D. Update on pollen-food allergy syndrome. Expert Rev Clin Immunol. 2020;16(6): 561–578. 10.1080/1744666X.2020.1774366
6. Inomata N, Miyakawa M, Ikeda N, Oda K, Aihara M. Identification of gibberellin-regulated protein as a new allergen in orange allergy. Clin Exp Allergy. 2018;48(11):1509–1520. 10.1111/cea.13247
7. Carlson G, Coop C. Pollen food allergy syndrome (PFAS): A review of current available literature. Ann Allergy Asthma Immunol. 2019;123(4):359–365. 10.1016/j.anai.2019.07.022
8. Skypala IJ, Jeimy S, Brucker H, et al. Cannabis-related allergies: An international overview and consensus recommendations. Allergy. 2022;77(7):2038–2052. 10.1111/all.15237
9. Asaumi T, Ebisawa M. How to manage food dependent exercise induced anaphylaxis (FDEIA). Curr Opin Allergy Clin Immunol. 2018;18(3):243–247. 10.1097/ACI.0000000000000442